Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast CancerN. Lynn Henry, Anna Maria Storniolo, Elizabeth Yakim et al.|Journal of Clinical Oncology|2012Cited by 391
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast CancerKunal C. Kadakia, N. Lynn Henry, Claire Snyder et al.|The Oncologist|2016Cited by 76
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortN. Lynn Henry, Vered Stearns, James M. Rae et al.|Breast Cancer Research and Treatment|2009Cited by 74
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancerDaniel L. Hertz, James M. Rae, Daniel F. Hayes et al.|The Pharmacogenomics Journal|2016Cited by 25